Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada
Study Identifier
P19-933
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female
Age
18 - 50 Years
Protocol Summary
The objective of this study is to evaluate real-world effectiveness of elagolix in Canadian women with endometriosis.
Study Locations
Location
Status
Location
South Health Campus Rheumatology Clinic /ID# 213065
Calgary, Alberta, Canada, T3M 1M4
Status
Not applicable
Location
Aubrey D. Uretsky Professional Corporation /ID# 214753
Edmonton, Alberta, Canada, T5T 1L6
Status
Not applicable
Location
BC Women's Hospital /ID# 214561
Vancouver, British Columbia, Canada, V6H 2N9
Status
Not applicable
Location
Strand Clinic /ID# 213567
St. John's, Newfoundland and Labrador, Canada, A1A 4Y3
Status
Not applicable
Location
IWK Health Center /ID# 213066
Halifax, Nova Scotia, Canada, B3K 6R8
Status
Not applicable
Location
Medicor Research Inc /ID# 213467
Greater Sudbury, Ontario, Canada, P3A 1W8
Status
Not applicable
Showing {first} - {last} of {total} Results